* Alimera Sciences Inc ALIM.OQ reported a quarterly adjusted
loss of 60 cents per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 52 cents per share.
* Revenue fell 2.6% to $12.15 million from a year ago; analysts
expected $12.37 million.
* The mean earnings estimate of analysts had fallen by
about 101.9% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Alimera Sciences Inc shares had risen by 2.1% this quarter and
gained 2.1% so far this year.
* The company reported a quarterly loss of $4.18 million.
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $14.50
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated October 28 at 01:33 p.m.
All figures in US dollars unless otherwise stated